"React19" partners with closed-loop care coordination and referral platform "CrossTx" and biomedical-focused media network "TrialSite" to develop the first ever provider, social supports, and mental health network for the vaccine-injured across the United States with an eye on international expansion.
Read MoreTubetorial just published an exclusive interview of Dominique Benoit, President and Founder of TSplus. The article tells the story of this software company expert in Remote Access technologies, and why their smart solutions have succeeded through Covid-19 crisis and offer a bright future to everyone involved.
Read MoreHR managers and company directors face one of their hardest challenges in modern times: managing the return of staff to places of work. As quoted in the Telegraph earlier this year, Rishi Sunak British politician & Chancellor of the Exchequer since 2020 said employees would "vote with their feet and would consider leaving for a rival if made to work from home full-time."
Read MoreHyris is going to present its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunology Symposium in Health, which will address strategies for the COVID-19 response and the development of the vaccines against SARS-CoV-2. This new solution leverages the Hyris System™, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform.
Read MoreHyris developed a rapid T-Cell test to track patients' immunity levels to SARS-CoV-2 for global clinical and research use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the power of the renowned HYRIS bCUBE™ and the whole Hyris SystemTM. This disruptive platform enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform.
Read MoreGen-Z-led non-profit Up To Us and polling partner INTRVL share detailed, county-level data on unvaccinated adults, who have a wide range of motivations for not getting the COVID-19 vaccine. There are 25 million people across the country who could be persuaded to get the shot. They are more concerned about adverse health effects in comparison to vaccine-resistant adults, who are more conspiratorial.
Read More75% of the survey participants have bought a fake product last year. 57% did so unwittingly. A large group of consumers is willing to buy a coronavirus vaccine online, making them extra vulnerable towards scammers.
Read MoreMore than 150 of the 1,384 CHCs around the country now use AccuVax and AccuShelf for vaccine and medication management in their facilities.
Read MoreActiv-2 trial provides opportunity to Miami dade County residents to participate in clinical research programs for COVID-19 with the newest medications through a private public partnership
Read MoreDowntown San Antonio community partners with a local technology company and global filtration experts to mitigate the indoor airborne spread of COVID-19 among visitors and residents
Read MoreInvitrx Therapeutics' continued efforts to be the leader in innovative cellular therapy had just recently been reinforced with the company's collaboration with Baylx, Inc. (Baylx) to co-sponsor and spearhead the clinical trial of Baylx's FDA approved IND for COVID-19 indication using Human Umbilical Cord Tissue Mesenchymal Stem Cells (hUC-MSC) product, as featured by BioInformant on November 23, 2020. This publication can be seen in full at https://bioinformant.com/invitrx-baylx-covid-19.
Read MoreDuring these uncertain times, many Arizonians are putting off their healthcare and coping with pain and disease. But the few who have ventured out have found health and wellbeing at Functional Wellness Center.
Read More